-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WLkxUAAFkRjtqVgSTO2zrbJXbZgyfvON3fIr7v9wDqL8GKr+CMEKMQ5OEbjH7gQW SZZ9RJS0k0zYWj2eLH47/Q== 0001426332-10-000001.txt : 20100405 0001426332-10-000001.hdr.sgml : 20100405 20100405172226 ACCESSION NUMBER: 0001426332-10-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100405 DATE AS OF CHANGE: 20100405 EFFECTIVENESS DATE: 20100405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NGM BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001426332 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-114428 FILM NUMBER: 10732261 BUSINESS ADDRESS: STREET 1: 2855 CHURCHILL DR CITY: HILLSBOROUGH STATE: CA ZIP: 94010 BUSINESS PHONE: 650-685-6655 MAIL ADDRESS: STREET 1: 2855 CHURCHILL DR CITY: HILLSBOROUGH STATE: CA ZIP: 94010 D 1 primary_doc.xml X0603 D LIVE 0001426332 NGM BIOPHARMACEUTICALS INC 630 Gateway Boulevard South San Francisco CA 94080 650-243-5555 DELAWARE None None Corporation true 2007 Jin-Long Chen c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA 94080 Executive Officer Director Luis Bayol c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA 94080 Executive Officer David V. Goeddel c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA 94080 Executive Officer Director Helen Kim c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA 94080 Executive Officer Marc Leschly c/o Rho Ventures 525 University Ave., Suite 1350 Palo Alto CA 94301 Director Arthur D. Levinson c/o NGM Biopharmaceuticals, Inc. 630 Gateway Boulevard South San Francisco CA 94080 Director David Schnell c/o Prospect Ventures, L.P. 435 Tasso St., Suite 200 Palo Alto CA 94301 Director Peter Svennilson 3121 Polo Drive Gulf Stream FL 33483 Director McHenry T. Tichenor, Jr. c/o Tichenor Ventures, LLC 100 Crescent Court, Suite 700 Dallas TX 75201 Director Biotechnology Decline to Disclose 06 false 2010-03-10 true true true Sale and issuance of Series B preferrred stock and the underlying shares of common stock issuable upon conversion thereof. false 0 51139000 17029670 34109330 false 19 0 0 0 false NGM BIOPHARMACEUTICALS INC Michael E. Tenta Michael E. Tenta Assistant Secretary 2010-03-30 -----END PRIVACY-ENHANCED MESSAGE-----